Obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Experimental group: >=18 years old, BMI >=28g/m^2, patients who plan to undergo gastric volume reduction surgery, sign the informed consent; 2. Control group:>=18 years, BMI<=28g/m^2, signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Suffering from coronary heart disease, severe aortic valve or mitral valve heart disease, hypertrophic heart disease, and other secondary cardiomyopathy; 2. Suffering from stroke, peripheral vascular disease, chronic kidney disease (eGFR<=60), heart failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| left ventriclar ejection fraction;left atrial diameter;left atrim volume;left ventriclar mass;early-diastolic ratio of left ventricular inflow velocity to mitral annular velocity;left bentricular mass index;peak flow rate ratio in early and late diastolic phases;interventricular septal thickness at end-diastole;global longitudinal strain;peak velocity of tricuspid regurgitation;troponin T;N-terminal pro-B-type natriuretic peptide; | — |
Secondary
| Measure | Time frame |
|---|---|
| the ratio of plasma neutrophils to lymphocytes;high sensitivty C-reactive protein;microalbuminuria;Serum creatinine;plasma total cholesterol;plasma triglyceride;plasma low density lipoprotein-cholesterol;plasma high density lipoprotein-cholesterol;lipoprotein(a); | — |
Countries
China
Contacts
China-Japan Friendship Hospital